HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Extrahepatic bile duct cancer, also known as cholangiocarcinoma, is a rare and aggressive type of cancer that originates in the bile ducts outside the liver. When cancerous cells develop in these ducts, it can impede the flow of bile, leading to various complications. This type of cancer is often challenging to diagnose in its early stages, as symptoms may not manifest until the disease has progressed. Common symptoms include jaundice, abdominal pain, unexplained weight loss, and itching. Due to the nonspecific nature of these symptoms, extrahepatic bile duct cancer is frequently diagnosed at an advanced stage, making treatment more difficult. Risk factors for developing extrahepatic bile duct cancer include age, chronic inflammation of the bile ducts (such as in conditions like primary sclerosing cholangitis), and certain infections. However, the exact cause of this cancer remains unclear. Treatment options for extrahepatic bile duct cancer typically involve a combination of surgery, chemotherapy, and radiation therapy. Surgical resection, if feasible, is considered the primary treatment, but it may not be an option for all patients due to the advanced stage of the disease or other health considerations. Prognosis for individuals with extrahepatic bile duct cancer varies depending on the stage at which it is diagnosed and the effectiveness of treatment. Unfortunately, the overall survival rate is often relatively low, emphasizing the importance of early detection and intervention.
